EZR and polycystic ovary syndrome: Recent studies have shown that the expression and localization of ezrin have been altered in tissues related to endometriosis (Peloggia et al., 2022), recurrent miscarriage (Zhang et al., 2022a), gestational trophoblastic disease (Tameishi et al., 2021), and polycystic ovary syndrome (PCOS) (Demacopulo and Kreimann, 2019), sparking our interest.